BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CFD Research Corporation Developing Non-Invasive Stem Cell Analyzer Technology


7/9/2013 10:53:06 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HUNTSVILLE, AL – July 9, 2013 -- CFD Research Corporation has been awarded a two-year $1M contract from the DoD’s Defense Health Program to continue their research into the detection and sorting of stem cells according to their differentiation states.

Currently no label-free methods exist to reliably determine the differentiation state of a stem cell in a non-invasive manner. CFDRC researchers say the ability to do so may transform the field of stem cell research and open a clear path to clinical use of stem cells for regenerative medicine.

"The emerging importance of induced pluripotent stem cells (iPSCs) as research tools and potential cell therapeutics makes this an important class of stem cells to study," said Kapil Pant, Ph.D and CFDRC director of biomedical technology. Pant said the project will use human iPSCs as a starting point to evaluate the ability of their novel stem cell analyzer to identify and sort iPSCs and derivative cells based on their state of differentiation.

“We have demonstrated a non-invasive and label free technique based upon electrical impedance measurement,” said fellow researcher Yi Wang, Ph.D and principal investigator. The technology includes a high-throughput sorting capability to collect and purify differentiated cells in a targeted pathway. “If you want to repair, for example, bone damage, you want to make sure you only use cells which have already differentiated along the bone cell pathway” said Wang.

Wang stressed the importance of non-invasive techniques. “Current methods to determine differentiation states require modification of the cell with biomarkers or destructive techniques leading to statistical population assessments and as such cannot guarantee the purity of the sample population. Our method will directly detect the differentiation state with minimum effects and result in a purified stream of pathway differentiated cells.”

Stem cells for regenerative medicine could have both military and non-military applications. It could improve the treatment of burns and wounds, significantly reducing the recovery process for patients. It could also accelerate the growth of cells for use in treating spinal cord injuries and neuro-degenerative disorders.

About CFDRC

CFD Research Corporation develops and commercializes innovative technologies for biomedical, energy, materials and aerospace markets. CFDRC, founded in 1987, is headquartered in Huntsville, Alabama

Contact

Richard Thoms

CFD Research Corporation

Manager, Technology Partnerships

256.726.4810

rdt@cfdrc.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES